title: Endovascular treatment of subarachnoid hemorrhage.
abstract: Aneurysmal subarachnoid hemorrhage (aSAH) is a common and devastating form of stroke. A large number of patients with aSAH develop angiographic or clinical vasospasm responsible for high morbidity and mortality. Rapid advances in the field of interventional neurology and the development of minimally invasive techniques have resulted in expansion of potential therapeutic applications. Treatment of aSAH has benefited from this rapid advance in the field of endovascular therapies. In the first section of the review, we discuss the therapeutic options and techniques for embolizations of intracranial aneurysms. In the second section, we discuss evolving endovascular treatment methods employed to intervene in delayed complications of cerebral vasospasm in patients with aSAH.
authors.affiliation: Zeenat Qureshi Stroke Research Center, Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA. kirmanjf@umdnj.edu
authors.forename: Jawad F
authors.initials: JF
authors.lastname: Kirmani
authors.forename: Ammar
authors.initials: A
authors.lastname: Alkawi
authors.forename: Shafiuddin
authors.initials: S
authors.lastname: Ahmed
authors.forename: Nazli
authors.initials: N
authors.lastname: Janjua
authors.forename: Ismail
authors.initials: I
authors.lastname: Khatri
authors.forename: Afshin A
authors.initials: AA
authors.lastname: Divani
authors.forename: Adnan I
authors.initials: AI
authors.lastname: Qureshi
mesh_terms: D000800:Angioplasty, Balloon; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D016019:Survival Analysis
chemical_list: D002121:Calcium Channel Blockers